by Mette Bach Dyremose | Aug 27, 2025 | News
In August 2025, a research project published in Human Reproduction attracted media attention by showing that paracetamol may impair the development of the fertilized egg in the very first days after conception. Paracetamol is the active compound in commonly used...
by Mette Bach Dyremose | Jun 25, 2025 | Spotlight Interview
What is your background and current role in ReproUnion? I am a Medical doctor and in February 2025, I began my PhD at the Fertility Clinic at Rigshospitalet, where I will use data from the ReproUnion Biobank & Infertility Cohort (RUBIC) in some parts of my...
by Mette Bach Dyremose | Jun 20, 2025 | News
ReproUnion returned to Folkemødet this year with its own event in the Interreg ÖKS-hosted tent, where Stine Gry Kristensen was showing real ovaries in small petri dishes. Did you know that human ovaries are among the fastest ageing organs in the body? And that it sets...
by Mette Bach Dyremose | Jun 6, 2025 | News
On 19-25 May it was European Mental Health Week – a timely opportunity to shed light on an often-overlooked challenge: the emotional strain that fertility treatments place on individuals and couples. The psychological toll includes high levels of stress, anxiety, and...
by Mette Bach Dyremose | May 28, 2025 | News
As one of the first commercial partners to access the ReproUnion Biobank & Infertility Cohort (RUBIC), Caerus Biotech is collaborating with Rigshospitalet to analyze samples from 1000 men, using the company’s MiOXSYS system designed to measure oxidative stress in...
